Alvogen Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALVOGEN
ALVOGEN has fifty-four approved drugs.
There are two tentative approvals on ALVOGEN drugs.
Summary for Alvogen
| US Patents: | 0 |
| Tradenames: | 44 |
| Ingredients: | 42 |
| NDAs: | 54 |
| Patent Litigation for Alvogen: | See patent lawsuits for Alvogen |
| PTAB Cases with Alvogen as petitioner: | See PTAB cases with Alvogen as petitioner |
Drugs and US Patents for Alvogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alvogen | PREGABALIN | pregabalin | TABLET, EXTENDED RELEASE;ORAL | 211593-003 | Apr 13, 2021 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alvogen | HYDROCODONE BITARTRATE | hydrocodone bitartrate | CAPSULE, EXTENDED RELEASE;ORAL | 206986-002 | Jan 21, 2020 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alvogen | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 208540-001 | Nov 8, 2018 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alvogen | PRIMAQUINE PHOSPHATE | primaquine phosphate | TABLET;ORAL | 203924-001 | Feb 3, 2014 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alvogen | OXYCODONE AND ACETAMINOPHEN | acetaminophen; oxycodone hydrochloride | TABLET;ORAL | 202677-003 | Mar 8, 2016 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Alvogen | MELPHALAN | melphalan | TABLET;ORAL | 207809-001 | Mar 22, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Alvogen | BUTALBITAL AND ACETAMINOPHEN | acetaminophen; butalbital | TABLET;ORAL | 205120-001 | Oct 30, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alvogen
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-002 | Oct 31, 1985 | 4,005,209 | ⤷ Start Trial |
| Alvogen | CICLOPIROX | ciclopirox | GEL;TOPICAL | 020519-001 | Jul 21, 1997 | 7,026,337 | ⤷ Start Trial |
| Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-003 | Aug 1, 1984 | 4,012,444 | ⤷ Start Trial |
| Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-004 | Aug 1, 1984 | 4,012,444 | ⤷ Start Trial |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-004 | Aug 23, 1988 | 4,005,209 | ⤷ Start Trial |
| Alvogen | TRANDATE | labetalol hydrochloride | TABLET;ORAL | 018716-001 | May 24, 1985 | 4,012,444 | ⤷ Start Trial |
| Alvogen | TAMBOCOR | flecainide acetate | TABLET;ORAL | 018830-004 | Aug 23, 1988 | 3,800,481 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
